| WO2009114512 |
20080311 |
Preparation of azetidine and cyclobutane derivatives as JAK
inhibitors |
Incyte Corporation, USA |
| WO2014028756 |
20140220 |
Deuterated baricitinib |
Concert Pharmaceuticals,
Inc., USA |
| JP5971830 |
20150428 |
Preparation of polycyclic pyridone
derivatives as cap-dependent endonuclease (CEN) inhibitors and prodrugs
thereof |
Shionogi and Co., Ltd., Japan |
| US20160122374 |
20141029 |
Preparation of nucleosides and methods for
treating Filoviridae virus infections |
Gilead Sciences, Inc., USA |
| US20170071964 |
20160916 |
Preparation of amino acid-containing
nucleotides and methods for treating arenaviridae and coronaviridae
virus infections |
Gilead Sciences, Inc., USA |
| WO2007075145 |
20070704 |
Preparation of benzopyranone derivatives as
anti-coronaviral agents |
Singapore Polytechnic, Singapore;
Shanghai Institute of Materia Medica Chinese Academy of Sciences,
China |
| WO2005021518 |
20050310 |
Preparation of 3,4-dihydro-2H-1,4-benzoxazine-2-carboxylic acid derivatives as cysLT2
receptor antagonists for treatment of respiratory diseases |
Ono Pharmaceutical Co., Ltd., Japan |
| WO2007120160 |
20071025 |
Preparation of N-heterocyclic acetamides useful for viral inhibition |
Novartis AG, USA |
| WO2009119167 |
20091001 |
Aniline derivative having anti-RNA
viral activity |
KinoPharma, Inc., Japan |
| WO2013049382 |
20130404 |
Broad-spectrum antivirals against 3c or 3c-like proteases of
picornavirus-like supercluster: picornaviruses, caliciviruses and
coronaviruses |
Kansas State University Research Foundation;
The Ohio State University; Wichita State University - all in USA |
| WO2018042343 |
20180308 |
Preparation of peptides that inhibit 3C and 3CL proteases and methods
of use thereof |
GlaxoSmithKline, UK |
| WO2007067515 |
20070614 |
Five-membered iminocyclitol derivatives as selective and potent
glycosidase inhibitors: new structures for antivirals and osteoarthritis
therapeutics |
Academia Sinica, Taiwan |
